Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.02B |
| 2 |
Apple
AAPL
|
+$789M |
| 3 |
Amazon
AMZN
|
+$651M |
| 4 |
NVIDIA
NVDA
|
+$442M |
| 5 |
Tesla
TSLA
|
+$423M |
Top Sells
| 1 |
KSU
Kansas City Southern
KSU
|
+$441M |
| 2 |
Aon
AON
|
+$184M |
| 3 |
JD.com
JD
|
+$173M |
| 4 |
VER
VEREIT, Inc.
VER
|
+$165M |
| 5 |
Dell
DELL
|
+$139M |
Sector Composition
| 1 | Technology | 26.23% |
| 2 | Healthcare | 13.24% |
| 3 | Financials | 12.99% |
| 4 | Consumer Discretionary | 11.99% |
| 5 | Communication Services | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Nature's Sunshine
NATR
$299M
| $3.91M | ﹤0.01% |
211,529
-34,833
| -14% | -$644K |
|
3027
Quince Therapeutics
QNCX
$85.9M
| $3.91M | ﹤0.01% |
309,601
-20,246
| -6% | -$255K |
|
3028
Alaunos Therapeutics
TCRT
$5.1M
| $3.9M | ﹤0.01% |
23,870
+1,606
| +7% | +$263K |
|
|
IMGO
3029
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $3.9M | ﹤0.01% |
164,613
+19,799
| +14% | +$469K |
|
|
AHT
3030
Ashford Hospitality Trust
AHT
$38.1M
| $3.9M | ﹤0.01% |
40,614
+6,802
| +20% | +$653K |
|
|
CBAY
3031
DELISTED
Cymabay Therapeutics
CBAY
| $3.89M | ﹤0.01% |
1,151,205
+44,114
| +4% | +$149K |
|
3032
Cardiff Oncology
CRDF
$136M
| $3.88M | ﹤0.01% |
645,084
+62,927
| +11% | +$378K |
|
3033
UBS Group
UBS
$129B
| $3.87M | ﹤0.01% |
216,831
-3,308
| -2% | -$59.1K |
|
3034
Bombardier Recreational Products
DOOO
$4.7B
| $3.87M | ﹤0.01% |
44,133
+299
| +0.7% | +$26.2K |
|
3035
Paymentus
PAY
$4.1B
| $3.87M | ﹤0.01% |
110,537
+39,859
| +56% | +$1.39M |
|
3036
Future Fuel
FF
$169M
| $3.86M | ﹤0.01% |
505,170
+55,150
| +12% | +$421K |
|
3037
Greif Class B
GEF.B
$2.46B
| $3.85M | ﹤0.01% |
64,442
-7,817
| -11% | -$467K |
|
3038
dLocal
DLO
$4.03B
| $3.85M | ﹤0.01% |
107,846
+748
| +0.7% | +$26.7K |
|
3039
eGain
EGAN
$220M
| $3.84M | ﹤0.01% |
385,147
+5,186
| +1% | +$51.7K |
|
3040
Evolus
EOLS
$465M
| $3.83M | ﹤0.01% |
588,800
+14,363
| +3% | +$93.5K |
|
3041
Shattuck Labs
STTK
$92M
| $3.83M | ﹤0.01% |
450,189
+18,746
| +4% | +$160K |
|
3042
Fresenius Medical Care
FMS
$14.7B
| $3.8M | ﹤0.01% |
117,210
-10,715
| -8% | -$348K |
|
3043
First Bank
FRBA
$413M
| $3.8M | ﹤0.01% |
261,736
-3,129
| -1% | -$45.4K |
|
|
DRRX
3044
DELISTED
DURECT Corp
DRRX
| $3.8M | ﹤0.01% |
385,026
-2,319
| -0.6% | -$22.9K |
|
|
NMTR
3045
DELISTED
9 Meters Biopharma, Inc. Common Stock
NMTR
| $3.78M | ﹤0.01% |
193,238
+12,035
| +7% | +$236K |
|
3046
Petrobras
PBR
$81.4B
| $3.76M | ﹤0.01% |
342,694
+554
| +0.2% | +$6.08K |
|
3047
Tourmaline Bio
TRML
$1.22B
| $3.76M | ﹤0.01% |
24,582
+7,448
| +43% | +$1.14M |
|
3048
Innovative Industrial Properties
IIPR
$1.6B
| $3.75M | ﹤0.01% |
14,279
+693
| +5% | +$182K |
|
3049
Donegal Group Class A
DGICA
$711M
| $3.74M | ﹤0.01% |
261,959
+6,560
| +3% | +$93.7K |
|
3050
Olympic Steel
ZEUS
$368M
| $3.74M | ﹤0.01% |
159,110
+646
| +0.4% | +$15.2K |
|